Rubia cordifolia L. Crude Aerial Part Extracts Show a High Potential as Antimalarials against Chloroquine Resistant Plasmodium falciparum Strains in vitro
1, 1, 2, 3
- 1Department of Zoological Sciences, Kenyatta University, Nairobi, KENYA.
- 2Department of Biomedical Sciences and Technology, The Technical University of Kenya, Nairobi, KENYA.
- 3Department of Tropical and Infectious Diseases, Institute of Primate Research, Nairobi, KENYA.
CORRESPONDENCE
Lucy Kamau
Department of Zoological Sciences, Kenyatta University, Nairobi, KENYA.
Received: 11-11-2022; Accepted: 11-01-2023.
Volume 15, Issue 2 · pp. 288-296 · 2023 · DOI: 10.5530/pres.15.2.031
ABSTRACT
Introduction: Plasmodium falciparum human malaria parasite is resistant to most available medicines in Africa, necessitating research for new drugs. Rubia cordifolia L. is used in traditional malaria treatment in Kenya despite no supporting scientific data.Objectives: To evaluate anti-plasmodial efficacy of extracts from the aerial part of Rubia cordifolia against chloroquine sensitive (3D7) and resistant (W2) Plasmodium falciparum strains.Methods: Hexane, methanol and water were separately used in crude extractions from open shade dried aerial plant parts. Phytochemical composition was determined qualitatively. Anti-plasmodial efficacy of serial dilutions (range; 0.4 to 50 μg/ml) of each extract were evaluated in vitro and compared using ANOVA and Tukey’s HSD test, at pmethanol>aqueous and were attributed to the phytochemicals present in the extracts. This presents evidence of R. cordifolia as anti-malarial drugs’ source. Further work is required to identify, purify, and characterize active molecules for development of anti-malaria drugs.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Jeremiah, M., Kamau, L., Nyambati, G., & Ozwara, H. (2023). Rubia cordifolia L. Crude Aerial Part Extracts Show a High Potential as Antimalarials against Chloroquine Resistant Plasmodium falciparum Strains in vitro. Pharmacognosy Research, 15(2), 288-296. https://doi.org/10.5530/pres.15.2.031
Copyright and licence
© 2023 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0
